IGC Pharma, Inc.
IGC Pharma, Inc. (IGC) is a Biotechnology company in the Healthcare sector, listed on New York Stock Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for IGC Pharma, Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Exchange
- New York Stock Exchange
- CEO
- Ram Mukunda
- Employees
- 67
- IPO date
- 24 May 2006
- ISIN
- US45408X3089
- Website
- igcpharma.com
Frequently asked questions
Where is IGC Pharma, Inc. stock listed?
IGC Pharma, Inc. (IGC) is listed on New York Stock Exchange.